Induction of Labor by Cervical Ripening and Transcutaneous Electrical Nerve Stimulation (TENS)

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorHOT Noémie

About this trial

This study aims to evaluate the effectiveness of transcutaneous electrical nerve stimulation (TENS) for pain management during labor induction by cervical ripening.

Labor induction is a common obstetric procedure and cervical ripening may be associated with painful uterine contractions. Non-pharmacological analgesic methods such as TENS could help improve pain management during this phase. However, evidence regarding its effectiveness in this context remains limited.

This randomized, controlled, open-label monocentric study will compare the use of TENS in addition to usual analgesic care versus usual analgesic care alone in pregnant women undergoing labor induction with cervical ripening. The primary objective is to assess whether TENS reduces the need for neuraxial analgesia or delays its use during labor.

Eligibility criteria

Qualifiers

Pregnant women aged 18 years or older

Gestational age ≥ 37 weeks of amenorrhea

Indication for labor induction requiring cervical ripening

Planned cervical ripening using oral misoprostol (Angusta)

Disqualifiers

Contraindication to labor induction by cervical ripening

Contraindication to epidural analgesia

Major fetal anomaly

Maternal hypertension or hypotension

Trial design

Treatments tested in this trial

  • Transcutaneous Electrical Nerve Stimulation (TENS)
  • Standard analgesic care

Treatment groups

132 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

HOT Noémie

Lead sponsor

Poissy-Saint Germain Hospital

Sponsor institution